The CVS Earnings Bombshell That Has Investors Scrambling Right Now
At a Glance Revenue: $105.69 billion (beat consensus of $104.63 billion) Adjusted EPS: $1.09 (beat consensus of $1.00) GAAP EPS: $2.30 vs. $1.30 prior year (includes $1.9 billion tax benefit from subsidiary bankruptcy) Full-Year 2025 Revenue: $402.1 billion, up 7.8%…
At a Glance
- Revenue: $105.69 billion (beat consensus of $104.63 billion)
- Adjusted EPS: $1.09 (beat consensus of $1.00)
- GAAP EPS: $2.30 vs. $1.30 prior year (includes $1.9 billion tax benefit from subsidiary bankruptcy)
- Full-Year 2025 Revenue: $402.1 billion, up 7.8%
- Stock Performance: Closed at $75.77 on February 9, down 3.76% year-to-date
Financial Performance Highlights
CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations. The 8.2% revenue increase to $105.69 billion marked the company’s strongest quarterly top-line growth of the year. However, adjusted EPS of $1.09 declined from $1.19 in Q4 2024, pressured by Medicare Part D headwinds from Inflation Reduction Act seasonality changes.
The GAAP EPS figure of $2.30 benefited significantly from a one-time $1.9 billion tax benefit related to the Omnicare subsidiary bankruptcy filing, masking underlying operational challenges.
Segment Performance
Health Care Benefits posted $36.29 billion in revenue (up 10.1%), but its adjusted operating loss widened to $676 million from $439 million the previous year. The segment shed 504,000 members year-over-year.
Health Services generated $51.24 billion in revenue (up 9.0%) with adjusted operating income rising 9.2%. Pharmacy & Consumer Wellness delivered $37.66 billion (up 12.4%), benefiting from Rite Aid prescription file acquisitions.
2026 Guidance
CVS confirmed adjusted EPS guidance of $7.00 to $7.20 for 2026, but reduced operating cash flow expectations to at least $9.0 billion from a prior $10.0 billion target, signaling continued pressure on working capital.
Contact [email protected] for any questions or corrections.
Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.
Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.
Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.
Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.
